We are live on ! Find out more
RXST icon

RxSight
RXST

40 hedge funds and large institutions have $75M invested in RxSight in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 7

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

3% more funds holding

Funds holding: 39 → 40 (+1)

4.63% less ownership

Funds ownership: 29% → 24.37% (-4.6%)

69% less capital inflows, than outflows

Capital inflows: $6.85M | Capital outflows: $22M

Holders
40
Holders Change
+1
Holders Change %
+2.56%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
19
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Sessa Capital
Sessa Capital
New York
+$1.97M
2
OrbiMed
OrbiMed
New York
+$1.6M
3
BlackRock
BlackRock
New York
+$550K
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$525K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$498K

Top Sellers

Rank Fund Capital Flow
1
Deerfield Management
Deerfield Management
New York
-$11.4M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$6.46M
3
Millennium Management
Millennium Management
New York
-$1.31M
4
CCM
CAAS Capital Management
New York
-$1.27M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$839K

RXST Hedge Fund Activity: Q4 2021 in Review

40 of the 6,522 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q4 2021, worth a combined $75M — down 25% from $100M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new RXST positions and 4 closed out — a net gain of 2 holders — while 19 added to existing stakes and 7 trimmed.

The largest buyer was Sessa Capital, opening a new position worth an estimated $1.97M. The largest seller was Deerfield Management, exiting entirely with an estimated $11.4M sold.

  • 40 institutional investors held RxSight (RXST) as of Q4 2021, up from 39 in Q3 2021.
  • Funds reported $75M of RxSight stock for Q4 2021, down 25% quarter-over-quarter.
  • 6 funds opened new RxSight positions in Q4 2021 and 4 closed out, a net change of +2 holders.
  • The largest RxSight buyer in Q4 2021 was Sessa Capital, an estimated $1.97M added.
  • The largest RxSight seller in Q4 2021 was Deerfield Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.